Laboratory diagnosis of SARS.
Identifieur interne : 000509 ( Pmc/Corpus ); précédent : 000508; suivant : 000510Laboratory diagnosis of SARS.
Auteurs : A. Bermingham ; P. Heinen ; M. Iturriza-G Mara ; J. Gray ; H. Appleton ; M C ZambonSource :
- Philosophical Transactions of the Royal Society B: Biological Sciences [ 0962-8436 ] ; 2004.
Abstract
The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.
Url:
DOI: 10.1098/rstb.2004.1493
PubMed: 15306394
PubMed Central: 1693399
Links to Exploration step
PMC:1693399Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Laboratory diagnosis of SARS.</title><author><name sortKey="Bermingham, A" sort="Bermingham, A" uniqKey="Bermingham A" first="A" last="Bermingham">A. Bermingham</name></author><author><name sortKey="Heinen, P" sort="Heinen, P" uniqKey="Heinen P" first="P" last="Heinen">P. Heinen</name></author><author><name sortKey="Iturriza G Mara, M" sort="Iturriza G Mara, M" uniqKey="Iturriza G Mara M" first="M" last="Iturriza-G Mara">M. Iturriza-G Mara</name></author><author><name sortKey="Gray, J" sort="Gray, J" uniqKey="Gray J" first="J" last="Gray">J. Gray</name></author><author><name sortKey="Appleton, H" sort="Appleton, H" uniqKey="Appleton H" first="H" last="Appleton">H. Appleton</name></author><author><name sortKey="Zambon, M C" sort="Zambon, M C" uniqKey="Zambon M" first="M C" last="Zambon">M C Zambon</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">15306394</idno><idno type="pmc">1693399</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693399</idno><idno type="RBID">PMC:1693399</idno><idno type="doi">10.1098/rstb.2004.1493</idno><date when="2004">2004</date><idno type="wicri:Area/Pmc/Corpus">000509</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000509</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Laboratory diagnosis of SARS.</title><author><name sortKey="Bermingham, A" sort="Bermingham, A" uniqKey="Bermingham A" first="A" last="Bermingham">A. Bermingham</name></author><author><name sortKey="Heinen, P" sort="Heinen, P" uniqKey="Heinen P" first="P" last="Heinen">P. Heinen</name></author><author><name sortKey="Iturriza G Mara, M" sort="Iturriza G Mara, M" uniqKey="Iturriza G Mara M" first="M" last="Iturriza-G Mara">M. Iturriza-G Mara</name></author><author><name sortKey="Gray, J" sort="Gray, J" uniqKey="Gray J" first="J" last="Gray">J. Gray</name></author><author><name sortKey="Appleton, H" sort="Appleton, H" uniqKey="Appleton H" first="H" last="Appleton">H. Appleton</name></author><author><name sortKey="Zambon, M C" sort="Zambon, M C" uniqKey="Zambon M" first="M C" last="Zambon">M C Zambon</name></author></analytic><series><title level="j">Philosophical Transactions of the Royal Society B: Biological Sciences</title><idno type="ISSN">0962-8436</idno><idno type="eISSN">1471-2970</idno><imprint><date when="2004">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Philos Trans R Soc Lond B Biol Sci</journal-id><journal-title>Philosophical Transactions of the Royal Society B: Biological Sciences</journal-title><issn pub-type="ppub">0962-8436</issn><issn pub-type="epub">1471-2970</issn></journal-meta><article-meta><article-id pub-id-type="pmid">15306394</article-id><article-id pub-id-type="pmc">1693399</article-id><article-id pub-id-type="doi">10.1098/rstb.2004.1493</article-id><article-id pub-id-type="pii">DP8XERF4FKHPPTP8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Laboratory diagnosis of SARS.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bermingham</surname><given-names>A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heinen</surname><given-names>P</given-names></name></contrib><contrib contrib-type="author"><name><surname>Iturriza-Gómara</surname><given-names>M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gray</surname><given-names>J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Appleton</surname><given-names>H</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zambon</surname><given-names>M C</given-names></name></contrib></contrib-group><aff>Enteric, Respiratory and Neurological Laboratory, Health Protection Agency Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK.</aff><pub-date pub-type="ppub"><day>29</day><month>7</month><year>2004</year></pub-date><volume>359</volume><issue>1447</issue><fpage>1083</fpage><lpage>1089</lpage><abstract><p>The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000509 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000509 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1693399
|texte= Laboratory diagnosis of SARS.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:15306394" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |